Wellington ICU Research

Wellington ICU has a strong research interest with links to the Clinical Trials Group of the Australian & New Zealand Intensive Care Society (ANZICS), the Australian and New Zealand Intensive Care Research Centre and the Medical Research Institute of New Zealand.

The unit participates in multi-centre & multi-national clinical trials that we believe will benefit both our patients and the advancement of knowledge in Intensive Care Medicine.

All trials that we participate in have prior Ethics Committee approval and trial participation is only by agreement of all the Senior Medical Staff.

The research nursing team work within the unit to ensure that data collection is accurate and that trial enrolment and treatment protocols are adhered to.

The research team have produced a brochure providing information for patients & their families.
This can be downloaded using the button to the right. Please ask a member of the research nursing team if would like a printed copy.

Research in ICU
Information for Patients

The Intensive Care Foundation is a charitable organisation formed by ANZICS in 1990. It works to raise money in New Zealand & Australia to improve the care of critically ill patients through research & the education of health professionals responsible for intensive care. More information on the vital work they do can be found by clicking the logo to the left.

Wellington Regional Hospital also has a Clinical Trials Unit, a dedicated clinical research facility funded by Capital & Coast District Health Board. The 14-bed unit is the first to be located in a New Zealand public hospital with access to a wide range of clinical specialists & networks.

Please select the logo above for more information.

CURRENT & UPCOMING TRIALS & STUDIES

The ADRENAL trial: steroids in adult ICU patients with severe sepsis
The SPICE III study: early goal-directed sedation practice in ICU patients
The TRANSFUSE trial: standard vs fresher red blood cell use in Intensive Care
The RELIEF study: Restrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery
The TRICS-III study: Transfusion Requirements in Cardiac Surgery III
The ICU-ROX study: avoidance of hyperoxaemia vs standard care in patients requiring prolonged mechanical ventilation
The ART-123 trial: recombinant human soluble thrombomodulin to treat disseminated intravascular coagulation in severe sepsis
The PEPTIC study: proton pump inhibitors vs histamine receptor blockers for stress ulcer prophylaxis in ICU
The TARGET trial: standard enteral nutrition vs energy dense nutrition in ICU
The PLUS study: saline vs Plasma-lyte for fluid resuscitation in sick ICU patients
The AT-II study: angiotensin-II for catecholamine refractory shock
CTG Point Prevalence Study

If you are a staff member of Wellington ICU looking for more information on current or upcoming trials, please use the button to the right or the menu bar at the top of the page.

TRIAL PROTOCOLS